Juvenile idiopathic arthritis: The paediatric perspective

Pediatric Radiology

Volumn 36, Issue 8, 2006, Pages 734-742

  Jordan, Alison ^a   McDonagh, Janet E ^a  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Arthritis; Children; Joint; Juvenile idiopathic arthritis

Indexed keywords

ALENDRONIC ACID; ANTIRHEUMATIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CORTICOSTEROID; CYCLOSPORIN; DICLOFENAC; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; FOLIC ACID; GROWTH HORMONE; HYDROXYCHLOROQUINE; IBUPROFEN; IMMUNOGLOBULIN; INDOMETACIN; INFLIXIMAB; MELOXICAM; METHOTREXATE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; ONDANSETRON; PAMIDRONIC ACID; PENICILLAMINE; PIROXICAM; RHEUMATOID FACTOR; ROFECOXIB; SALAZOSULFAPYRIDINE; TRIAMCINOLONE ACETONIDE; TRIAMCINOLONE HEXACETONIDE; TUMOR NECROSIS FACTOR ANTIBODY; UNINDEXED DRUG;

AUTOLOGOUS STEM CELL TRANSPLANTATION; AVASCULAR NECROSIS; BACTERIAL ARTHRITIS; BEHAVIOR DISORDER; BLOOD TOXICITY; BONE DENSITY; BONE MARROW SUPPRESSION; CARCINOGENESIS; CHILD; CHILD HEALTH CARE; CLINICAL FEATURE; CLINICAL TRIAL; CONCENTRATION LOSS; CORTICOSTEROID INDUCED OSTEOPOROSIS; CUSHINGOID SYNDROME; DEMYELINATING DISEASE; DEPIGMENTATION; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE CONTROL; DRUG ABSORPTION; DRUG ALCOHOL INTERACTION; DRUG BIOAVAILABILITY; DRUG COST; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG PULSE THERAPY; EARLY DIAGNOSIS; ECHOGRAPHY; ENTHESITIS; ENVIRONMENTAL FACTOR; GASTROINTESTINAL SYMPTOM; GENETIC RISK; GINGIVA HYPERPLASIA; GROWTH DISORDER; HEALTH PROMOTION; HIRSUTISM; HUMAN; INCIDENCE; INFECTION; INTERSTITIAL LUNG DISEASE; JOINT PROSTHESIS; JOINT RADIOGRAPHY; JUVENILE RHEUMATOID ARTHRITIS; LIVER TOXICITY; LYMPHOMA; MOOD CHANGE; MORBIDITY; MOUTH ULCER; MUTAGENICITY; NAUSEA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PATIENT EDUCATION; PHOBIA; PHYSIOTHERAPY; POLYARTHRITIS; PRIORITY JOURNAL; PROGNOSIS; PSEUDOPORPHYRIA; PSORIATIC ARTHRITIS; PSYCHOLOGICAL ASPECT; REMISSION; RISK FACTOR; SHORT SURVEY; SIDE EFFECT; SKIN ATROPHY; SLIT LAMP; SOCIAL CARE; SYNOVITIS; TERATOGENICITY; TUBERCULOSIS; UVEITIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; ARTHROGRAPHY; CHILD; FEMALE; HUMANS; MALE;

EID: 33746515615     PISSN: 03010449     EISSN: 14321998     Source Type: Journal    
DOI: 10.1007/s00247-006-0165-7     Document Type: Short Survey

References (86)

1. Murray K, Thompson SD, Glass DN (1997) Pathogenesis of juvenile chronic arthritis: Genetic and environmental factors. Arch Dis Child 77:530-534
2. Symmons DP, Jones M, Osborne J, et al (1996) Pediatric rheumatology in the United Kingdom: Data from the British Paediatric Rheumatology Group National Diagnostic Register. J Rheumatol 23:1975-1980
3. Petty RE (2002) Frequency of uncommon diseases: Is juvenile idiopathic arthritis under recognized? J Rheumatol 29:1356-1357
4. Glass DN, Gianni EH (1999) Juvenile rheumatoid arthritis as a complex genetic trait. Arthritis Rheum 42:2261-2268
5. Thomson W, Donn R (2002) Juvenile idiopathic arthritis genetics - what's new? What's next? Arthritis Res 4:302-306
6. Prahalad S (2004) Genetics of juvenile idiopathic arthritis: An update. Curr Opin Rheumatol 16:588-594
7. Petty RE, Southwood TR, Manners P, et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: Second revision, Edmonton, 2001. J Rheumatol 31:390-392
8. Edelsten C (2002) An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood. Br J Ophthalmol 86:1-2
9. Guillaume S, Prieur AM, Coste J, et al (2000) Long-term outcome and prognosis in oligoarticular-onset juvenile idiopathic arthritis. Arthritis Rheum 43:1858-1865
10. Burgos-Vargas R, Clark P (1989) Axial involvement in the seronegative enthesopathy and arthropathy syndrome and its progression to ankylosing spondylitis. J Rheumatol 16:192-197
11. Myers A, McDonagh JE, Gupta K, et al (2004) More 'cries from the joints': Assessment of the musculoskeletal system is poorly documented in routine paediatric clerking. Rheumatology (Oxford) 43:1045-1049
12. Miller ML (2002) Use of imaging in the differential diagnosis of rheumatic diseases in children. Rheum Dis Clin North Am 28:483-492
13. Johnson K (2006) Minisymposium - juvenile idiopathic arthritis. Imaging. Pediatr Radiol DOI:10.1007/s00247-006-0199-x
14. Hackett J, Johnson B, Parkin A, et al (1996) Physiotherapy and occupational therapy for juvenile chronic arthritis: Custom and practice in five centres in the UK, USA and Canada. Br J Rheumatol 35:695-699
15. Giannini EH, Brewer EJ, Kuzmina N, et al (1992) Methotrexate in resistant juvenile rheumatoid arthritis. Results of the USA-USSR double-blind, placebo-controlled trial. The Paediatric Rheumatology Collaborative Study Group. N Engl J Med 326:1043-1049
16. Lovell DJ, Giannini EH, Reiff A, et al (2000) Etanercept in children with polyarticular juvenile rheumatoid arthritis. Paediatric Rheumatology Collaborative Study Group. N Engl J Med 342:763-769
17. Padeh S, Passwell JH (1998) Intraarticular corticosteroid injection in the management of children with chronic arthritis. Arthritis Rheum 41:1210-1214
18. Cleary AG, Murphy HD, Davidson JE (2003) Intraarticular corticosteroid injections in juvenile idiopathic arthritis. Arch Dis Child 88:192-196
19. Eberhard BA, Sison MC, Gottlieb BS, et al (2004) Comparison of the intraarticular effectiveness of triamcinolone hexacetonide and triamcinolone acetonide in treatment of juvenile rheumatoid arthritis. J Rheumatol 31:2507-2512
20. Chakravarty K, Pharoah PD, Scott DG (1994) A randomised controlled trial of post-injection rest following steroid therapy for knee synovitis. Br J Rheumatol 33:464-468
21. Job-Deslandre C, Menkes CJ (1990) Complications of intraarticular injections of triamcinolone hexacetonide in chronic arthritis in children. Clin Exp Rheumatol 8:413-416
22. Huppertz H-I, Tschammler A, Horwitz AE, et al (1995) Intraarticular corticosteroids for chronic arthritis in children: Efficacy and effects on cartilage and growth. J Pediatr 127:317-321
23. Wallace CA (1999) On beyond methotrexate treatment of severe juvenile rheumatoid arthritis. Clin Exp Rheumatol 17:499-504
24. Adebajo AO, Hall MA (1998) The use of intravenous pulsed methylprednisolone in the treatment of systemic-onset juvenile chronic arthritis. Br J Rheumatol 37:1240-1242
25. Woo P, Southwood TR, Prieur AM, et al (2000) Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. Arthritis Rheum 43:1849-1857
26. Ramanan AV, Whitworth P, Baildam EM (2003) Use of methotrexate in juvenile idiopathic arthritis. Arch Dis Child 88:197-200
27. Ruperto N, Murray K, Gerloni V, et al (2004) Pediatric Rheumatology International Trials Organization. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Arthritis Rheum 50:2191-2201
28. van Ede AE, Laan RF, Rood MJ, et al (2001) Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: A forty-eight week, multicentre, randomized, double-blind, placebo-controlled study. Arthritis Rheum 44:1515-1524
29. Cleary AG, McDowell H, Sills JA (2002) Polyarticular juvenile idiopathic arthritis treated with methotrexate complicated by the development of non-Hodgkin's lymphoma. Arch Dis Child 86:47-49
30. van Rossum MA, Fiselier TJ, Franssen JA, et al (1998) Sulfasalazine in the treatment of juvenile chronic arthritis. Arthritis Rheum 41:808-816
31. Mouy R, Stephan JL, Pillet P, et al (1996) Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases. J Pediatr 129:750-754
32. Emery HM (1993) Treatment of juvenile rheumatoid arthritis. Curr Opin Rheumatol 5:629-633
33. Silverman ED, Cawkwell GD, Lovell DJ, et al (1994) Intravenous immunoglobulin in the treatment of systemic juvenile rheumatoid arthritis: A randomized placebo controlled trial. Pediatric Rheumatology Collaborative Study Group. J Rheumatol 21:2353-2358
34. Uziel Y, Laer RM, Schneider R, et al (1996) Intravenous immunoglobulin therapy in systemic onset juvenile rheumatoid arthritis: A follow-up study. J Rheumatol 23:910-918
35. Wilkinson N, Jackson G, Gardner-Medwin J (2003) Biologic therapies for juvenile arthritis. Arch Dis Child 88:201-205
36. Keystone EC, Schiff MH, Kremer JM, et al (2004) Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: Results of a multicentre, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 50:353-363
37. van der Heijde D, Klareskog L, Singh A, et al (2006) Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: The TEMPO trial. Ann Rheum Dis 65:328-334
38. Lovell DJ, Giannini EH, Reiff A, et al; Pediatric Rheumatology Collaborative Study Group (2003) Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: Interim results from an ongoing multicenter, open-label, extended-treatment trial. Arthritis Rheum 48:218-226
39. Gerloni V, Pontikaki I, Gattinara M, et al (2005) Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: Results of an open-label prospective study. Arthritis Rheum 52:548-553
40. Dekker L, Armhurst W, Rademaker CM, et al (2004) Safety of anti-TNF alpha therapy in children with juvenile idiopathic arthritis. Clin Exp Rheumatol 22:252-258
41. Billiau AD, Wouters C (2000) Improved articular and systemic disease in a boy treated with anti-TNFα monoclonal antibody (Remicade) for refractory JIA. Ann Rheum Dis 59 [Suppl 1]:47
42. British Paediatric Rheumatology Group (2000) Guidelines for the prescribing of biologic agents for children and young adults with juvenile idiopathic arthritis. British Paediatric Rheumatology Group, April 2000 (http://www.rheumatology.org.uk)
43. NICE (2002) Guidance on the use of etanercept for the treatment of juvenile idiopathic arthritis. Technology Appraisal Guidance No. 35. National Institute for Clinical Excellence, March 2002 (http://www.nice.org.uk)
44. Wedderburn LR, Abinun M, Palmer P, et al (2003) Autologous haematopoietic stem cell transplantation in juvenile idiopathic arthritis. Arch Dis Child 88:201-205
45. Shaw KL, Southwood TR, McDonagh JE; British Society of Paediatric and Adolescent Rheumatology (2005) Growing up and moving on in rheumatology: a multicentre cohort of adolescents with juvenile idiopathic arthritis. Rheumatology (Oxford) 44:806-812
46. Packham JC, Hall MA, Pimm TJ (2002) Long-term follow up of 246 adults with juvenile idiopathic arthritis: Predictive factors for mood and pain. Rheumatology 41:1444-1449
47. Sherry DD, Bohnsack J, Salmonson K, et al (1990) Painless juvenile rheumatoid arthritis. J Pediatr Psychol 12:241-255
48. Ilowite NT, Walco GA, Pochaczevsky R (1992) Assessment of pain in patients with juvenile rheumatoid arthritis: Relation between pain intensity and degree of joint inflammation. Ann Rheum Dis 51:343-346
49. Simon D, Touati G, Prieur AM, et al (1999) Growth hormone treatment of short stature and metabolic dysfunction in juvenile chronic arthritis. Acta Paediatr Suppl 88:100-105
50. Simon D, Lucidarme N, Prieur AM, et al (2003) Effects on growth and body composition of growth hormone treatment in children with juvenile idiopathic arthritis requiring steroid therapy. J Rheumatol 30:2492-2499
51. Bechtold S, Ripperger P, Bonfig W, et al (2005) Growth hormone changes bone geometry and body composition in patients with juvenile idiopathic arthritis requiring glucocorticoid treatment: A controlled study using peripheral quantitative computed tomography. J Clin Endocrinol Metab 90:3168-3173
52. Henderson CJ, Specker BL, Sierra RI, et al (2000) Total body bone mineral content in non-corticosteroid treated postpubertal females with juvenile rheumatoid arthritis. Arthritis Rheum 43:531-540
53. Schonau E (1998) Problems of bone analysis in childhood and adolescence. Pediatr Nephrol 12:420-429
54. Shaw NJ, Bishop NJ (2005) Bisphosphonate treatment of bone disease. Arch Dis Child 90:494-499
55. Warady B, Lindsley C, Robinson R, et al (1994) Effects of nutritional supplementation on bone mineral status of children with rheumatic disease receiving corticosteroid therapy. J Rheumatol 21:530-535
56. Petty RE, Smith JR, Rosenbaum JT (2003) Arthritis and uveitis in children. A pediatric rheumatology perspective. Am J Ophthalmol 135:879-884
57. Malik AR, Pavesio C (2005) The use of low dose methotrexate in children with chronic anterior and intermediate uveitis. Br J Ophthalmol 89:806-808
58. Foeldvari I, Wierk A (2005) Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis. J Rheumatol 32:362-365
59. Packham JC, Hall MA (2002) Long-term follow-up of 246 adults with juvenile idiopathic arthritis: Functional outcome. Rheumatology (Oxford) 41:1428-1435
60. McDonagh JE, Southwood TR, Shaw KL (2006) Growing up and moving on in rheumatology: Development and preliminary evaluation of a transitional care programme for a multicentre cohort of adolescents with juvenile idiopathic arthritis. J Child Health Care 10:22-42
61. Shaw KL, Southwood TR, McDonagh JE, et al (2005) Growing up and moving on in rheumatology: Transitional care and quality of life in a multicentre cohort of adolescents with juvenile idiopathic arthritis. Rheumatology (Oxford) 44 [Suppl 1]:199
62. Shaw KL, Southwood TR, McDonagh JE, et al (2004) Developing a programme of transitional care for adolescents with juvenile idiopathic arthritis: results of a postal survey. Rheumatology (Oxford) 43:211-219
63. Ullrich G, Mattussek S, Dressler F, et al (2002) How do adolescents with juvenile chronic arthritis consider their disease related knowledge, their unmet service needs and the attractiveness of various services? Eur J Med Res 7:8-18
64. Barlow JH, Shaw KL, Harrison K (1999) Consulting the 'experts': children's and parents' perceptions of psycho-educational interventions in the context of juvenile chronic arthritis. Health Educ Res 14:597-610
65. Klein JD, Allan MJ, Elster AB, et al (2001) Improving adolescent preventive care in community health centers. Pediatrics 107:318-327
66. Gage H, Hampson S, Skinner TC, et al (2004) Educational and psychosocial programmes for adolescents with diabetes: Approaches, outcomes and cost effectiveness. Patient Educ Couns 53:333-346
67. Kyngas H (2003) Patient education: Perspective of adolescents with a chronic disease. J Clin Nurs 12:744-751
68. Guevara JP, Wolf FM, Grum CM, et al (2003) Effects of educational interventions for self management of asthma in children and adolescents: systematic review and meta-analysis. BMJ 326:1308-1309
69. McDonagh JE, Southwood TR, Shaw KL, et al (2005) Growing up and moving on in rheumatology: Disease knowledge in a multicentre cohort of adolescents with juvenile idiopathic arthritis. Arch Dis Child 90 [Suppl II]:A51
70. Klepper S, Darbee J, Effgenr SK, et al (1992) Physical fitness levels in children with polyarticular juvenile rheumatoid arthritis. Arthritis Care Res 5:93-100
71. Petersen LS, Mason T, Nelson AM, et al (1997) Psychosocial outcomes and health studies in adults who have had juvenile arthritis: A controlled population based study. Arthritis Rheum 40:2235-2240
72. Stewart AL, Hays RD, Wells KB, et al (1994) Long-term functioning and well-being outcomes associated with physical activity and exercise in patients with chronic conditions in the Medical outcomes study. J Clin Epidemiol 47:719-730
73. Kotaniemi A, Savolainen A, Kroger H, et al (1999) Weight-bearing physical activity, calcium intake, systemic glucocorticoids, chronic inflammation and body constitution as determinants of lumbar and femoral bone mineral in juvenile chronic arthritis. Scand J Rheumatol 28:19-26
74. Nash AA, Britto MT, Lovell DJ, et al (1998) Substance use among adolescents with juvenile rheumatoid arthritis. Arthritis Care Res 11:391-396
75. Suris JC, Resnick MD, Cassuto N, et al (1996) Sexual behaviour of adolescents with chronic disease and disability. J Adolesc Health 19:124-131
76. Blumenfeld Z, Lorber M, Yoffe N, et al (1994) Systemic lupus erythematosus: Predisposition for uterine cervical dysplasia. Lupus 3:59-61
77. Packham JC, Hall MA (2002) Long-term follow-up of 246 adults with juvenile idiopathic arthritis: Social function, relationships and sexual activity. Rheumatology (Oxford) 41:1440-1443
78. Ostensen M, Almberg K, Koksvik HS (2000) Sex, reproduction and gynecological disease in young adults with a history of juvenile chronic arthritis. J Rheumatol 27:1783-1787
79. Britto MT, Rosenthal SL, Taylor J, et al (2000) Improving rheumatologists' screening for alcohol use and sexual activity. Arch Pediatr Adolesc Med 154:478-483
80. Giannini EH, Ruperto N, Ravelli A, et al (1997) Preliminary definition of improvement in juvenile in juvenile arthritis. Arthritis Rheum 40:1202-1209
81. Gare BA, Fasth A (1995) The natural history of juvenile chronic arthritis: A population based cohort study. II. Outcome. J Rheumatol 22:308-319
82. David J, Cooper C, Hickey L, et al (1994) The functional and psychological outcomes of juvenile chronic arthritis in young adulthood. Br J Rheumatol 33:876-881
83. Ruperto N, Levinson JE, Ravelli A, et al (1997) Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. I. Outcome status. J Rheumatol 24:945-951
84. Foster HE, Marshall N, Myers A, et al (2003) Outcome in adults with juvenile idiopathic arthritis: A quality of life study. Arthritis Rheum 48:767-775
85. Oen K, Malleson P, Cabral DA, et al (2002) Disease course and outcome of juvenile rheumatoid arthritis in a multicentre cohort. J Rheumatol 29:1989-1999
86. Packham JC, Hall MA (2002) Long-term follow-up of 246 adults with juvenile idiopathic arthritis: Education and employment. Rheumatology (Oxford) 41:1436-1439